1. Home
  2. TVTX vs ZGN Comparison

TVTX vs ZGN Comparison

Compare TVTX & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • ZGN
  • Stock Information
  • Founded
  • TVTX 2008
  • ZGN 1910
  • Country
  • TVTX United States
  • ZGN Italy
  • Employees
  • TVTX N/A
  • ZGN N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • ZGN Apparel
  • Sector
  • TVTX Health Care
  • ZGN Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • ZGN Nasdaq
  • Market Cap
  • TVTX 1.7B
  • ZGN 2.0B
  • IPO Year
  • TVTX N/A
  • ZGN N/A
  • Fundamental
  • Price
  • TVTX $15.02
  • ZGN $8.60
  • Analyst Decision
  • TVTX Strong Buy
  • ZGN Buy
  • Analyst Count
  • TVTX 14
  • ZGN 2
  • Target Price
  • TVTX $33.31
  • ZGN $8.05
  • AVG Volume (30 Days)
  • TVTX 1.9M
  • ZGN 973.0K
  • Earning Date
  • TVTX 05-01-2025
  • ZGN 03-27-2025
  • Dividend Yield
  • TVTX N/A
  • ZGN 1.58%
  • EPS Growth
  • TVTX N/A
  • ZGN N/A
  • EPS
  • TVTX N/A
  • ZGN 0.31
  • Revenue
  • TVTX $273,533,000.00
  • ZGN $2,015,371,157.00
  • Revenue This Year
  • TVTX $74.41
  • ZGN $0.79
  • Revenue Next Year
  • TVTX $48.90
  • ZGN $4.69
  • P/E Ratio
  • TVTX N/A
  • ZGN $27.69
  • Revenue Growth
  • TVTX 75.65
  • ZGN 2.21
  • 52 Week Low
  • TVTX $6.79
  • ZGN $6.05
  • 52 Week High
  • TVTX $25.29
  • ZGN $12.77
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 35.45
  • ZGN 61.94
  • Support Level
  • TVTX $16.37
  • ZGN $8.37
  • Resistance Level
  • TVTX $15.48
  • ZGN $8.70
  • Average True Range (ATR)
  • TVTX 1.00
  • ZGN 0.23
  • MACD
  • TVTX -0.51
  • ZGN -0.03
  • Stochastic Oscillator
  • TVTX 3.83
  • ZGN 65.29

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About ZGN Ermenegildo Zegna N.V.

Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.

Share on Social Networks: